US Stock MarketDetailed Quotes

GLPGF GALAPAGOS NV

Watchlist
  • 24.550
  • 0.0000.00%
15min DelayClose Aug 9 16:00 ET
1.62BMarket Cap5.15P/E (TTM)

About GALAPAGOS NV Company

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Company Profile

SymbolGLPGF
Company NameGALAPAGOS NV
Listing DateMay 14, 2015
Founded1999
CEODr. Paulus Stoffels
MarketPink Market
Employees1123
Fiscal Year Ends12-31
AddressIndustriepark Mechelen Noord,Generaal de Wittelaan L11 A3
CityMechelen
ProvinceBrussels Region
CountryBelgium
Zip Code2800
Phone32-1-534-29-00
Websitehttp://www.glpg.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Paulus Stoffels
  • Chairman of the Supervisory Board and Chief Executive Officer
  • 1.97M
  • Annelies Missotten
  • Chief Human Resources Officer and Executive Vice President
  • --
  • Thad Allen Huston
  • Chief Financial Officer, Chief Operating Officer and Executive Vice President
  • --
  • Valeria Cnossen
  • General Counsel and Executive Vice President
  • --
  • Simon John Sturge
  • Independent Director
  • 28.13K
  • Dr. Susanne Schaffert, PhD
  • Independent Director
  • 60.24K
  • Peter Guenter
  • Member of the Supervisory Board
  • 115.00K
  • Jerome Contamine
  • Member of the Supervisory Board
  • 150.00K
  • Dr. Elisabeth Svanberg
  • Member of the Supervisory Board
  • 138.75K
  • Daniel G. Baker
  • Member of the Supervisory Board
  • 117.36K
  • Dr. Linda Higgins, PhD
  • Member of the Supervisory Board
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg